INTRODUCTION
heart valve disease, Pericardium Organic Valvular Bioprosthesis, congenital malformations, arthritis
INFECTIOUS DISEASES, DEGENERATION, RHEUMATIC DISEASES, ADVERSE EVENTS, ARTHRITIS, HEART VALVE DISEASE, HEART, DISEASES
Heart valve is a structure in the circulatory system that allows blood to flow only
in one direction and is closely associated with hemodynamic function but can be
susceptible to serious pathologies resulting from congenital malformations,
rheumatic diseases, infectious diseases, arthritis, and structural degeneration
caused primarily by calcificationTreatment options for heart valve disease include medication, surgical repair, or
replacement. Based on the material used in cardiac valve prostheses, there are two
major categories: (a) bioprosthesis or biological valves made basically of animal
tissue, such as bovine pericardium, and (b) mechanical valves made of synthetic
materialsAlthough biological valves are practically non-thrombogenicThe Bovine Pericardium Organic Valvular Bioprosthesis (BVP) (Braile
Biomédica®) was introduced to clinical use in 1977. Based on results
of several studies, this valve is widely and successfully used to treat valve
diseases. BVP exhibits excellent hemodynamics and a minimal rate of valve-related
adverse events (AEs). In this article, we presented actual results from a
retrospective trial investigating this prosthesis in a cohort of patients undergoing
surgical valve replacement.